ID

40558

Description

ICHOM Lung cancer data collection Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. For Lung Cancer, the following conditions and treatment approaches (or interventions) are covered by our Standard Set. Conditions: Small Cell and Non-Small Cell Lung Cancer Treatment Approaches: Surgery | Radiotherapy | Chemotherapy | Targeted Therapy | Immunotherapy | Other This document contains Baseline - Clinical Form. It depicts first doctor's visit. Collecting Patient-Reported Outcome Measures: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). European Organization for Research and Treatment of Cancer Quality of Life Lung Cancer-Specific Questionnaire (EORTC QLQ-LC13). Both are free for all health care organizations, but a license is needed for use. http:// groups.eortc.be/qol/eortc-qlq-c30 is the official distribution site for EORTC QLQ-C30 and EORTC QLQ-LC13 questionnaire. Therefore only the total score will be included in this version of the standard set. Publication: Mak KS, van Bommel AC, Stowell C, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016;48(3):852–860. doi:10.1183/13993003.02049-2015 For this standard set ICHOM was supported by the Alliance of Dedicated Cancer Centers. For this version of the standard set, semantic annotation with UMLS CUIs has been added.

Link

http://www.ichom.org/

Keywords

Versions (3)
  1. 5/15/19 5/15/19 -
  2. 5/16/19 5/16/19 -
  3. 4/30/20 4/30/20 - Sarah Riepenhausen
Copyright Holder

ICHOM

Uploaded on

April 30, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

ICHOM Lung Cancer

English

Baseline - Clinical Form

1 forms  
Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Indicate the patient's medical record number
Description

Supporting Definition: This number will not be shared with ICHOM. In the case patient-­‐level data is submitted to ICHOM for benchmarking or research purposes, a separate ICHOM Patient Identifier will be created and cross-­‐linking between the ICHOM Patient Identifier and the medical record number will only be known at the treating institution Inclusion Criteria: All patients Timing: On all forms Data Source: Administrative or clinical Type: Numerical Response Options: According to institution

Data type

integer

Alias
UMLS CUI [1]
C2348585
Demographic factors
Description

Demographic factors

Alias
UMLS CUI-1
C1704791
What is your date of birth?
Description

Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical or patient-­‐reported Type: Date by DD/MM/YYYY

Data type

date

Measurement units
  • DD/MM/YYYY
Alias
UMLS CUI [1]
C0421451
DD/MM/YYYY
Please indicate your sex at birth
Description

Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical or patient-­‐reported Type: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0079399
Baseline Clinical Factors
Description

Baseline Clinical Factors

Alias
UMLS CUI-1
C0449440
UMLS CUI-2
C1442488
Indicate the absolute value of FEV-1 at time of lung cancer diagnosis
Description

Inclusion Criteria: Patients undergoing surgery Timing: Baseline Data Source: Clinical Type: Numerical value Response Options: Numerical value in liters 999 = Unknown

Data type

float

Measurement units
  • L
Alias
UMLS CUI [1,1]
C0024119
UMLS CUI [1,2]
C0429706
L
Indicate the percentage predicted value of FEV-1 at time of lung cancer diagnosis
Description

Inclusion Criteria: Patients undergoing surgery Timing: Baseline Data Source: Clinical Type: Numerical value Response Options: Numerical value of 0‐100 999 = Unknown

Data type

float

Measurement units
  • %
Alias
UMLS CUI [1,1]
C0024119
UMLS CUI [1,2]
C0086715
%
Baseline tumor factors
Description

Baseline tumor factors

Alias
UMLS CUI-1
C0475752
UMLS CUI-2
C1442488
Indicate how lung cancer was diagnosed
Description

Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C2911685
UMLS CUI [1,2]
C0332140
UMLS CUI [2,1]
C2911685
UMLS CUI [2,2]
C1521733
Indicate the lung cancer histology
Description

Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1]
C0019638
Indicate presence of ALK translocation
Description

Supporting Definition: If the test is not performed, unknown can be answered. Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0026882
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0252409
UMLS CUI [1,4]
C0040715
Indicate presence of activating EGFR mutation
Description

Supporting Definition: If the test is not performed, unknown can be answered. Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0026882
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C2984891
Indicate the clinical tumor stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: Pathologic staging preferred, if available cT0: no primary tumor cT1: if not able to select T1a or T1b: Tumor ≤3 cm diameter, surrounded by lung or visceral pleura, without invasion more proximal than lobar bronchus cT1a: Tumor ≤2 cm in diameter cT1b: Tumor >2 cm but ≤3 cm in diameter cT2: if not able to select T2a or T2b: Tumor >3 cm but ≤7 cm, or tumor with any of the following features: Involves main bronchus, ≥2 cm distal to carina. Invades visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung cT2a: Tumor >3 cm but ≤5 cm cT2b: Tumor >5 cm but ≤7 cm cT3: Tumor >7 cm or any of the following: Directly invades any of the following: chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, main bronchus <2 cm from carina (without involvement of carina), Atelectasis or obstructive pneumonitis of the entire lung. Separate tumor nodules in the same lobe cT4: Tumor of any size that invades the mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, or with separate tumor nodules in a different ipsilateral lobe cTX: Primary tumor cannot be assessed Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0205210
UMLS CUI [1,2]
C1300072
Indicate the clinical nodal stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: Pathologic staging preferred, if available cN0: No regional lymph node metastases cN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension cN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) cN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) cNX: Regional lymph nodes were not assessed Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0456532
UMLS CUI [1,2]
C0205210
Indicate clinical metastatic stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: cM0: No distant metastasis cM1: Distant metastasis cM1a: Separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion cM1b: Distant metastasis (in extrathoracic organs) cMX: Distant metastasis cannot be evaluated Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C0456533
UMLS CUI [1,2]
C0205210
Indicate pathological metastatic stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: pM0: No distant metastasis pM1: Distant metastasis pM1a: Separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion pM1b: Distant metastasis (in extrathoracic organs) pMX: Distant metastasis cannot be evaluated Inclusion Criteria: All patients Timing: Baseline Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1,1]
C1521733
UMLS CUI [1,2]
C0036525
UMLS CUI [1,3]
C1300072
Degree of health
Description

Degree of health

Alias
UMLS CUI-1
C0018759
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
Description

Supporting Definition: ECOG / WHO scale: - PS = 0 normal activity level; -­ PS = 1 restricted with strenuous activity, but can do light activity; -­ PS = 2 active >/= 50% of day; -­ PS = 3 spends >50% of day in chair or bed; -­ PS = 4 totally confined to bed Inclusion Criteria: All patients Timing: Baseline 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer

Data type

integer

Alias
UMLS CUI [1]
C1520224
Back to the top of the page

Similar models

Baseline - Clinical Form

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Patient ID
Item
Indicate the patient's medical record number
integer
C2348585 (UMLS CUI [1])
Item Group
Demographic factors
C1704791 (UMLS CUI-1)
Date of birth
Item
What is your date of birth?
date
C0421451 (UMLS CUI [1])
Item
Please indicate your sex at birth
integer
C0079399 (UMLS CUI [1])
Sex
Code List
Please indicate your sex at birth
CL Item
Male (1)
C0086582 (UMLS CUI-1)
(Comment:en)
CL Item
Female (2)
C0086287 (UMLS CUI-1)
(Comment:en)
CL Item
Undisclosed (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item Group
Baseline Clinical Factors
C0449440 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Pulmonary function at lung cancer diagnosis: Absolute value FEV-1
Item
Indicate the absolute value of FEV-1 at time of lung cancer diagnosis
float
C0024119 (UMLS CUI [1,1])
C0429706 (UMLS CUI [1,2])
Pulmonary function at lung cancer diagnosis: Percent predicted normal value
Item
Indicate the percentage predicted value of FEV-1 at time of lung cancer diagnosis
float
C0024119 (UMLS CUI [1,1])
C0086715 (UMLS CUI [1,2])
Item Group
Baseline tumor factors
C0475752 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Item
Indicate how lung cancer was diagnosed
integer
C2911685 (UMLS CUI [1,1])
C0332140 (UMLS CUI [1,2])
C2911685 (UMLS CUI [2,1])
C1521733 (UMLS CUI [2,2])
Method of diagnosis (clinical or pathologic)
Code List
Indicate how lung cancer was diagnosed
CL Item
Clinical assessment (1)
C4534461 (UMLS CUI-1)
(Comment:en)
CL Item
Histological assessment (2)
C0449575 (UMLS CUI-1)
C1516048 (UMLS CUI-2)
(Comment:en)
CL Item
Cytological assessment (3)
C0205471 (UMLS CUI-1)
C1516048 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate the lung cancer histology
integer
C0019638 (UMLS CUI [1])
Histology
Code List
Indicate the lung cancer histology
CL Item
Adenocarcinoma (1)
C0001418 (UMLS CUI-1)
(Comment:en)
CL Item
Adenocarcinoma with lepidic pattern (2)
C0001418 (UMLS CUI-1)
C1881368 (UMLS CUI-2)
(Comment:en)
CL Item
Invasive mucinous adenocarcinoma (3)
C0007130 (UMLS CUI-1)
C0205281 (UMLS CUI-2)
(Comment:en)
CL Item
Squamous cell carcinoma (4)
C0007137 (UMLS CUI-1)
(Comment:en)
CL Item
Small‐cell carcinoma (5)
C0262584 (UMLS CUI-1)
(Comment:en)
CL Item
Non-­small cell lung cancer (NSCLC) – favor adenocarcioma (6)
C0007131 (UMLS CUI-1)
C0001418 (UMLS CUI-2)
(Comment:en)
CL Item
NSCLC – favor squamous cell carcinoma (7)
C0007131 (UMLS CUI-1)
C0007137 (UMLS CUI-2)
(Comment:en)
CL Item
NSCLC with neuroendocrine (NE) morphology and positive NE markers; (8)
C0007131 (UMLS CUI-1)
C1709218 (UMLS CUI-2)
C1265996 (UMLS CUI-3)
C0332149 (UMLS CUI-4)
(Comment:en)
CL Item
NSCLC with NE morphology (negative NE markers) (9)
C0007131 (UMLS CUI-1)
C1709218 (UMLS CUI-2)
C1265996 (UMLS CUI-3)
C0205160 (UMLS CUI-4)
(Comment:en)
CL Item
NSCLC with spindle and/or giant cell carcinoma (10)
C0007131 (UMLS CUI-1)
C0682540 (UMLS CUI-2)
C0007097 (UMLS CUI-3)
C0206703 (UMLS CUI-4)
(Comment:en)
CL Item
NSCLC‐not otherwise specified (11)
C0007131 (UMLS CUI-1)
C1518425 (UMLS CUI-2)
(Comment:en)
CL Item
Atypical adenomatous hyperplasia (12)
C0334001 (UMLS CUI-1)
(Comment:en)
CL Item
Adenocarcinoma in situ (13)
C0001418 (UMLS CUI-1)
C0007099 (UMLS CUI-2)
(Comment:en)
CL Item
Minimally invasive adenocarcinoma (14)
C0001418 (UMLS CUI-1)
C1881856 (UMLS CUI-2)
(Comment:en)
CL Item
Carcinoid typical (NET grade 1) (15)
C0007095 (UMLS CUI-1)
(Comment:en)
CL Item
Carcinoid atypical (NET grade 2) (16)
C0007095 (UMLS CUI-1)
C0205182 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate presence of ALK translocation
integer
C0026882 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0252409 (UMLS CUI [1,3])
C0040715 (UMLS CUI [1,4])
Mutation status: ALK translocation
Code List
Indicate presence of ALK translocation
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
Failed analysis (2)
C0231175 (UMLS CUI-1)
C0936012 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate presence of activating EGFR mutation
integer
C0026882 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C2984891 (UMLS CUI [1,3])
Mutation status: ALK translocation
Code List
Indicate presence of activating EGFR mutation
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
Failed analysis (2)
C0231175 (UMLS CUI-1)
C0936012 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate the clinical tumor stage (per UICC / IASLC / AJCC 7th)
integer
C0205210 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
Clinical tumor stage
Code List
Indicate the clinical tumor stage (per UICC / IASLC / AJCC 7th)
CL Item
c T0 (0)
C0475371 (UMLS CUI-1)
C1275863 (UMLS CUI-2)
(Comment:en)
CL Item
cT1 (1)
C0475372 (UMLS CUI-1)
C1275863 (UMLS CUI-2)
(Comment:en)
CL Item
cT1a (2)
C1275863 (UMLS CUI-1)
C0475383 (UMLS CUI-2)
(Comment:en)
CL Item
cT1b (3)
C1275863 (UMLS CUI-1)
C0475385 (UMLS CUI-2)
(Comment:en)
CL Item
cT2 (4)
C1275863 (UMLS CUI-1)
C0475373 (UMLS CUI-2)
(Comment:en)
CL Item
cT2a (5)
C1275863 (UMLS CUI-1)
C0475387 (UMLS CUI-2)
(Comment:en)
CL Item
cT2b (6)
C1275863 (UMLS CUI-1)
C0475388 (UMLS CUI-2)
(Comment:en)
CL Item
cT3 (7)
C0475374 (UMLS CUI-1)
C1275863 (UMLS CUI-2)
(Comment:en)
CL Item
cT4 (8)
C0475751 (UMLS CUI-1)
C1275863 (UMLS CUI-2)
(Comment:en)
CL Item
cTX (9)
C0332377 (UMLS CUI-1)
C1275863 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate the clinical nodal stage (per UICC / IASLC / AJCC 7th)
integer
C0456532 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
Clinical nodal stage
Code List
Indicate the clinical nodal stage (per UICC / IASLC / AJCC 7th)
CL Item
cN0 (0)
C1275865 (UMLS CUI-1)
C0441959 (UMLS CUI-2)
(Comment:en)
CL Item
cN1 (1)
C1275865 (UMLS CUI-1)
C0441962 (UMLS CUI-2)
(Comment:en)
CL Item
cN2 (2)
C1275865 (UMLS CUI-1)
C0441960 (UMLS CUI-2)
(Comment:en)
CL Item
cN3 (3)
C1275865 (UMLS CUI-1)
C0441961 (UMLS CUI-2)
(Comment:en)
CL Item
cNX (4)
C1275865 (UMLS CUI-1)
C0445085 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C1275865 (UMLS CUI-1)
C0439673 (UMLS CUI-2)
(Comment:en)
Item
Indicate clinical metastatic stage (per UICC / IASLC / AJCC 7th)
integer
C0456533 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
Clinical metastatic stage
Code List
Indicate clinical metastatic stage (per UICC / IASLC / AJCC 7th)
CL Item
cM0 (0)
C0445034 (UMLS CUI-1)
C1275856 (UMLS CUI-2)
(Comment:en)
CL Item
cM1 (1)
C0441971 (UMLS CUI-1)
C1275856 (UMLS CUI-2)
(Comment:en)
CL Item
cM1a (2)
C0445036 (UMLS CUI-1)
C1275856 (UMLS CUI-2)
(Comment:en)
CL Item
cM1b (3)
C0445064 (UMLS CUI-1)
C1275856 (UMLS CUI-2)
(Comment:en)
CL Item
cMX (4)
C0445039 (UMLS CUI-1)
C1275856 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C1275856 (UMLS CUI-1)
C0439673 (UMLS CUI-2)
(Comment:en)
Item
Indicate pathological metastatic stage (per UICC / IASLC / AJCC 7th)
integer
C1521733 (UMLS CUI [1,1])
C0036525 (UMLS CUI [1,2])
C1300072 (UMLS CUI [1,3])
Pathological metastatic stage
Code List
Indicate pathological metastatic stage (per UICC / IASLC / AJCC 7th)
CL Item
pM0 (0)
C0332402 (UMLS CUI-1)
(Comment:en)
CL Item
pM1 (1)
C0456957 (UMLS CUI-1)
(Comment:en)
CL Item
pM1a (2)
C2733084 (UMLS CUI-1)
(Comment:en)
CL Item
pM1b (3)
C2733110 (UMLS CUI-1)
(Comment:en)
CL Item
pMX (4)
C0332404 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item Group
Degree of health
C0018759 (UMLS CUI-1)
Item
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
integer
C1520224 (UMLS CUI [1])
ECOG/WHO performance status
Code List
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
CL Item
0 (0)
C1828078 (UMLS CUI-1)
(Comment:en)
CL Item
1 (1)
C1827388 (UMLS CUI-1)
(Comment:en)
CL Item
2 (2)
C1828242 (UMLS CUI-1)
(Comment:en)
CL Item
3 (3)
C1827126 (UMLS CUI-1)
(Comment:en)
CL Item
4 (4)
C1827528 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C1520224 (UMLS CUI-2)
(Comment:en)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial